Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Margreet Franken; Brenda Leeneman; A Jochems; MG Schouwenburg; MJB Aarts; ACJ Akkooi; F van den Berkmortel; AJM Van den Eertwegh; JWB de Groot; JJM van der Hoeven; GAP Hospers; E Kapiteijn; RH Koornstra; Wim Kruit; MW Louwman; D Piersma; RS van Rijn; KPM Suijkerbuijk; AJ ten Tije; G Vreugdenhil; MWJM Wouters; M Zeijl; JBAG Haanen; Carin Uyl - de Groot

doi:10.1097/CAD.0000000000000628

Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

Margreet Franken, Brenda Leeneman, A Jochems, MG Schouwenburg, MJB Aarts, ACJ Akkooi, F van den Berkmortel, AJM Van den Eertwegh, JWB de Groot, JJM van der Hoeven, GAP Hospers, E Kapiteijn, RH Koornstra, Wim Kruit, MW Louwman, D Piersma, RS van Rijn, KPM Suijkerbuijk, AJ ten Tije, G VreugdenhilMWJM Wouters, M Zeijl, JBAG Haanen, Carin Uyl - de Groot

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

23 Downloads (Pure)

Original language	English
Pages (from-to)	579-588
Number of pages	10
Journal	Anti-Cancer Drugs
Volume	29
Issue number	6
DOIs	https://doi.org/10.1097/CAD.0000000000000628
Publication status	Published - 2018

Research programs

EMC NIHES-05-63-02 Quality
EMC MM-03-86-08

Access to Document

10.1097/CAD.0000000000000628

REPUB_107300.pdfFinal published version, 270 KBLicence: Article 25fa Dutch Copyright Act

http://hdl.handle.net/1765/107300

Cite this

Franken, M., Leeneman, B., Jochems, A., Schouwenburg, MG., Aarts, MJB., Akkooi, ACJ., van den Berkmortel, F., Van den Eertwegh, AJM., de Groot, JWB., van der Hoeven, JJM., Hospers, GAP., Kapiteijn, E., Koornstra, RH., Kruit, W., Louwman, MW., Piersma, D., van Rijn, RS., Suijkerbuijk, KPM., ten Tije, AJ., ... Uyl - de Groot, C. (2018). Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands. Anti-Cancer Drugs, 29(6), 579-588. https://doi.org/10.1097/CAD.0000000000000628

@article{9bfa0600d69a44d7876fede3cd69ac08,

title = "Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands",

author = "Margreet Franken and Brenda Leeneman and A Jochems and MG Schouwenburg and MJB Aarts and ACJ Akkooi and {van den Berkmortel}, F and {Van den Eertwegh}, AJM and {de Groot}, JWB and {van der Hoeven}, JJM and GAP Hospers and E Kapiteijn and RH Koornstra and Wim Kruit and MW Louwman and D Piersma and {van Rijn}, RS and KPM Suijkerbuijk and {ten Tije}, AJ and G Vreugdenhil and MWJM Wouters and M Zeijl and JBAG Haanen and {Uyl - de Groot}, Carin",

year = "2018",

doi = "10.1097/CAD.0000000000000628",

language = "English",

volume = "29",

pages = "579--588",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams & Wilkins",

number = "6",

}

Franken, M, Leeneman, B, Jochems, A, Schouwenburg, MG, Aarts, MJB, Akkooi, ACJ, van den Berkmortel, F, Van den Eertwegh, AJM, de Groot, JWB, van der Hoeven, JJM, Hospers, GAP, Kapiteijn, E, Koornstra, RH, Kruit, W, Louwman, MW, Piersma, D, van Rijn, RS, Suijkerbuijk, KPM, ten Tije, AJ, Vreugdenhil, G, Wouters, MWJM, Zeijl, M, Haanen, JBAG & Uyl - de Groot, C 2018, 'Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands', Anti-Cancer Drugs, vol. 29, no. 6, pp. 579-588. https://doi.org/10.1097/CAD.0000000000000628

TY - JOUR

T1 - Real-world healthcare costs of ipilimumab in patients with advanced cutaneous melanoma in The Netherlands

AU - Franken, Margreet

AU - Leeneman, Brenda

AU - Jochems, A

AU - Schouwenburg, MG

AU - Aarts, MJB

AU - Akkooi, ACJ

AU - van den Berkmortel, F

AU - Van den Eertwegh, AJM

AU - de Groot, JWB

AU - van der Hoeven, JJM

AU - Hospers, GAP

AU - Kapiteijn, E

AU - Koornstra, RH

AU - Kruit, Wim

AU - Louwman, MW

AU - Piersma, D

AU - van Rijn, RS

AU - Suijkerbuijk, KPM

AU - ten Tije, AJ

AU - Vreugdenhil, G

AU - Wouters, MWJM

AU - Zeijl, M

AU - Haanen, JBAG

AU - Uyl - de Groot, Carin

PY - 2018

Y1 - 2018

U2 - 10.1097/CAD.0000000000000628

DO - 10.1097/CAD.0000000000000628

M3 - Article

C2 - 29634490

SN - 0959-4973

VL - 29

SP - 579

EP - 588

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

IS - 6

ER -